What GLP-Compliant Toxicology Testing Means for Regulatory Submissions

GLP-compliant toxicology testing means the safety study was planned, performed, recorded, and archived under Good Laboratory Practice quality systems, so the resulting data can be submitted to regulators as part of a safety assessment. It matters most when a submission depends on study data being accepted by agencies such as the EPA or international bodies, and when the study must follow a recognized test guideline (OECD, ISO, EPA, or DOT). MB Research Laboratories is a contract research organization (CRO) that positions its toxicology services this way: GLP-compliant studies supporting global regulatory submissions for pharmaceuticals, medical devices, chemicals, and consumer products.

Why "GLP-compliant" is different from "a good study"

A scientifically sound study is not automatically a regulatory-ready one. GLP adds the controls that let a reviewer trust the data:

• Defined protocols and standard operating procedures so the study design is fixed before it starts.
• Documented roles and training for personnel running and overseeing the study.
• Raw data capture and traceability, so every reported value can be traced back to its source.
• Equipment calibration and facility controls that establish the conditions under which data were generated.
• Archiving that preserves records for the period regulators require.
• A quality assurance function independent of the study staff, auditing the work and reporting to management.

The practical consequence: when a regulator reviews a submission, GLP documentation is what allows the study to stand as evidence rather than as an internal finding.

How GLP compliance connects to test guidelines

GLP and test guidelines are two different things, and submissions usually need both.

A study can follow an OECD guideline without being GLP-compliant, and it can be run under GLP without following a recognized guideline. For a regulatory submission, the useful combination is a guideline-based design executed under GLP.

What this looks like across product types

MB Research organizes its work by assay type and by industry, which maps onto how regulatory requirements differ:

• Pharmaceuticals, chemicals, and consumer products — acute toxicity testing aligned with OECD TG 420, 423, 425, 402, and 403, supporting hazard classification and regulatory safety assessments.
• Medical devices — biocompatibility studies under ISO 10993, covering cytotoxicity, irritation, and sensitization to support device biocompatibility evaluations.
• Cosmetics and personal care — in vitro alternatives for ocular irritation, dermal irritation, phototoxicity, and corrosivity, aimed at reducing reliance on animal models while meeting scientific standards. MB Research notes work within frameworks such as the EU Cosmetics Directive (76/768/EEC).
• Consumer products broadly — oral, dermal, and inhalation exposure studies intended to meet CPSC, EPA, and international requirements.

The recurring pattern: the guideline and the regulatory framework change by product, but the GLP layer is what makes the data submittable.

Choosing a lab: what to verify

If you are selecting a CRO for a submission-bound study, these are the questions that determine whether the data will be usable:

1. Is the specific study you need offered under GLP? Ask for the compliance statement for that assay, not the lab's general claim.
2. Which guideline does the design follow? For eye and skin work, confirm the OECD TG number; for devices, confirm the relevant ISO 10993 part.
3. Which regulatory frameworks does the lab routinely support? MB Research cites OECD, EPA, ISO, and DOT standards, and names CPSC and EU Cosmetics Directive requirements among the frameworks it helps clients navigate.
4. Does the lab have a track record in your product class? MB Research states over 50 years of GLP-compliant toxicology and safety assessment work across five core industries.
5. Can it support the submission, not just the benchwork? Ask how study reports are structured for the agency you are filing with.

Common points of confusion

• "GLP-certified" is not a standard term. GLP compliance is typically established through inspection and adherence to the applicable national GLP regulations, not a single universal certificate.
• A validated in vitro method is not automatically GLP-compliant. Validation addresses whether the method measures what it claims; GLP addresses how the study was run and documented.
• Guideline numbers are not interchangeable. OECD TG 437, 492, 439, and 431 address different endpoints, so the correct one depends on the claim you need to support.
• One study rarely covers every market. Because agencies differ, confirm that the study design and report format match each jurisdiction you plan to file in.

Where to start

If your goal is a regulatory submission, work backward from the requirement: identify the agency and framework, identify the guideline the agency expects, then confirm the lab runs that guideline under GLP and has done so for your product type. MB Research's service pages are organized by assay type and industry, which makes it straightforward to check whether a specific test — eye and skin safety, biocompatibility, acute toxicity, or skin sensitization — is offered under the standards your submission requires.